[Significance of sequential monitoring of serum IL-18 in renal allograft recipients].
To study the clinical significance of early diagnosis and differential diagnosis of IL-18 by observing its changes in renal allograft recipients with infection, acute rejection and CsA-induced nephrotoxicity. The sequential monitoring of serum IL-18 in 90 patients was conducted by ELISA technique before and after renal transplantation with 30 healthy people as control. The levels of serum IL-18 levels in the patients for renal transplantation was significantly higher than that in control before operation(P<0.01). The level of serum IL-18 increased on the first day after transplantation, decreased and stabilized after 10 days. However, it maintained the high levels in acute rejection. The level of IL-18 rapidly decreased with effective methylpredmisolone impaction therapy, but persisted at high level when the therapy did not work. IL-18 also increased in infection, but compared with that in CsA-induced nephrotoxicity, there was no significant difference. The sequential monitoring of serum IL-18 in renal allograft recipients is a useful method to make early and differential diagnosis of acute renal rejection.